Protein Technologies Protein Technologies is a company that provides contract research services to the biotechnology industry. | Boston Institute of Biotechnology Boston Institute of Biotechnology is a contract research and development organization. | ![]() Thousand Oaks Biopharmaceuticals Thousand Oaks Biopharmaceuticals (澳斯康生物制药) is a company that provides contract research and manufacturing services with a focus on cell line development. | ![]() Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | ![]() Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | |
Founding Date | Founding Date 2010 | Founding Date 2014 | Founding Date 2017 | Founding Date 2012 | Founding Date 2013 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Manchester, GB HQ Manchester, GB | Locations Southborough, US HQ | Locations Nantong, CN HQ | Locations Berkeley, US HQ | Locations Cambridge, US HQ Boulder, US Cambridge, US |
Employees | Employees 811% decrease | Employees 355% decrease | Employees 43 | Employees 1477% decrease | Employees 20816% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 174.4 m | Valuation ($) 256.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $11.2m (FY, 2025) | Revenue (est.) $40.5m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($148.1m) (FY, 2025) | Net income ($160.1m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 107.6m | Total funding raised $ 159.5m | Total funding raised $ 210m |
Boston Institute of Biotechnology is a contract research and development organization.
View company
Thousand Oaks Biopharmaceuticals (澳斯康生物制药) is a company that provides contract research and manufacturing services with a focus on cell line development.
View company
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company